ETANERCEPT

etanercept 50 mg/mL injection, 4 x 1 mL syringes

ETANERCEPT (13698Y)

etanercept 50 mg/mL injection, 4 x 1 mL syringes
13698Y
Body System:
Manner of administration:Injection
General Schedule
Authority Required

Restriction

Indication: Severe active rheumatoid arthritis
Treatment phase: Initial treatment - Initial 1 (new patient)

Restriction

Indication: Severe active rheumatoid arthritis
Treatment phase: Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)

Restriction

Indication: Severe active rheumatoid arthritis
Treatment phase: Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 3 DPMQ: $846.42 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Brenzys
Erelzi
Nepexto